Personal factors in systemic sclerosis and their coverage by patient-reported outcome measures: A multicentre European qualitative study and literature review

European Journal of Physical and Rehabilitation Medicine

Volumn 51, Issue 4, 2015, Pages 405-421

  Mattsson, M ^a,b   Bostrom C ^c   Mihai, C ^d   Stocker J ^e,f   Geyh, S ^g,h   Stummvoll, G ⁱ   Gard, G ^a   Moller B ^b   Hesselstrand, R ^j   Sandqvist, G ^j   Draghicescu, O ^d   Gherghe, A M ^d   Voicu, M ^k   Distler, O ^l   Smolen, J S ⁱ   Stamm, T A ^i,m  

^a LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f HAN UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^g UNIVERSITY OF LUCERNE   (Switzerland)

^h SWISS PARAPLEGIC RESEARCH   (Switzerland)

ⁱ UNIVERSITY OF VIENNA   (Austria)

^j LUND UNIVERSITY   (Sweden)

^k GESIS LEIBNIZ INSTITUTE FOR THE SOCIAL SCIENCES   (Germany)

^l UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^m Fachhochschule Campus Wien   (Austria)

more..

Author keywords

Multicentre study; Qualitative research; Questionnaires; Review; Scleroderma; Systemic

Indexed keywords

DISABILITY; EUROPE; HUMAN; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; QUALITATIVE RESEARCH; SCLERODERMA, SYSTEMIC;

DISABILITY EVALUATION; EUROPE; HUMANS; MULTICENTER STUDIES AS TOPIC; PATIENT OUTCOME ASSESSMENT; QUALITATIVE RESEARCH; SCLERODERMA, SYSTEMIC;

EID: 84929266232     PISSN: 19739087     EISSN: 19739095     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
2. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37:223-35.
3. Barnes J, Mayes MD. Epidemiology of systemic sclerosis: Incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol 2012;24:165-70.
4. Matucci-Cerinic M, Steen VD, Furst DE, Seibold JR. Clinical trials in systemic sclerosis: Lessons learned and outcomes. Arthritis Res Ther 2007;9(Suppl 2):7.
5. Pope JE. Musculoskeletal involvement in scleroderma. Rheum Dis Clin North Am 2003;29:391-408.
6. Stamm TA, Mattsson M, Mihai C, Stöcker J, Binder A, Bauernfeind B et al. Concepts of functioning and health important to people with systemic sclerosis: A qualitative study in four european countries. Ann Rheum Dis 2011;70:1074-9.
7. Cinar FI, Unver V, Cinar M, Yilmaz S, Simsek I, Tosun N et al. Coping strategies for activities of daily living in women whose hands affected by systemic sclerosis. J Clin Nurs 2014;23:1630-8.
8. Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M. Disease and symptom burden in systemic sclerosis: A patient perspective. J Rheumatol 2007;34:1718-26.
9. Sandqvist G, Scheja A, Hesselstrand R. Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis. Rheumatology (Oxford) 2010;49:1739-46.
10. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, et al. Health-related quality of life in systemic sclerosis: A systematic review. Arthritis Rheum 2009;61:1112-20.
11. Arat S, Verschueren P, De Langhe E, Smith V, Vanthuyne M, Diya L et al. The association of illness perceptions with physical and mental health in systemic sclerosis patients: An exploratory study. Musculoskeletal Care 2012;10:18-28.
12. World Health Organization. International classification of functioning, disability and health (ICF). Geneva: World Health Organization; 2001.
13. Müller R, Geyh S. Lessons learned from different approaches towards classifying personal factors. Disabil Rehabil 2014;26:1-9.
14. Geyh S, Muller R, Peter C, Bickenbach JE, Post MW, Stucki G et al. Capturing the psychologic-personal perspective in spinal cord injury. Am J Phys Med Rehabil 2011;90:S79-96.
15. Schwegler U, Peter C, Trezzini B, Geyh S. Toward transparent documentation in medical work capacity evaluations: Identifying personal factors in medical reports on Swiss disability claimants with chronic widespread pain. Int J Rehabil Res 2013;36:298-307.
16. Joachim G, Acorn S. Life with a rare chronic disease: The scleroderma experience. J Adv Nurs 2003;42:598-606.
17. Malterud K. The art and science of clinical knowledge: Evidence beyond measures and numbers. Lancet 2001;358:397-400.
18. Mendelson C, Poole JL. Become your own advocate: Advice from women living with scleroderma. Disabil Rehabil 2007;29:1492-501.
19. Khanna D, Distler O, Avouac J, Behrens F, Clements PJ, Denton C et al. Measures of response in clinical trials of systemic sclerosis: The combined response index for systemic sclerosis (CRISS) and outcome measures in pulmonary arterial hypertension related to systemic sclerosis (EPOSS). J Rheumatol 2009;36:2356-61.
20. Geyh S, Peter C, Muller R, Bickenbach JE, Kostanjsek N, Ustun BT et al. The personal factors of the international classification of functioning, disability and health in the literature - a systematic review and content analysis. Disabil Rehabil 2011;33:1089-102.
21. Kaplan RM, Frosch DL. Decision making in medicine and health care. Annu Rev Clin Psychol 2005;1:525-56.
22. Devin NJ, Appleby J. Getting the most out of PROMS. putting health outcomes at the heart of NHS decision-making [Internet]. Available from: https://www.kingsfund.org.uk/sites/files/kf/Getting-the-most-out-of-PROMs-Nancy-Devlin-John-Appleby-Kings-Fund-March-2010.pdf [cited 2015, Apr 2].
23. Preliminary criteria for the classification of systemic sclerosis (scleroderma). subcommittee for scleroderma criteria of the american rheumatism association diagnostic and therapeutic criteria committee. Arthritis Rheum 1980;23:581-90.
24. Health at a Glance: Europe 2010. Paris: Organisation for Economic Co-operation and Development; 2010.
25. Bambra C, Eikemo TA. Welfare state regimes, unemployment and health: a comparative study of the relationship between unemployment and self-reported health in 23 European countries. J Epidemiol Community Health 2009;63:92-8.
26. Polit DF, Beck CT. Nursing research: Generating and assessing evidence for nursing practice. 9th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012.
27. Stamm T, van der Giesen F, Thorstensson C, Steen E, Birrell F, Bauernfeind B, et al. Patient perspective of hand osteoarthritis in relation to concepts covered by instruments measuring functioning: A qualitative european multicentre study. Ann Rheum Dis 2009;68:1453-60.
28. Kvale S. Interviews: An introduction to qualitative research interviewing. Thousand Oaks: Sage; 1996.
29. Khanna D, Lovell DJ, Giannini E, Clements PJ, Merkel PA, Seibold JR, et al. Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis 2008;67:703-9.
30. Smarr KL, Keefer AL. Measures of depression and depressive symptoms: Beck depression inventory-II (BDI-II), center for epidemiologic studies depression scale (CES-D), geriatric depression scale (GDS), hospital anxiety and depression scale (HADS), and patient health questionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):454-66.
31. Ware JE,Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med Care 1992;30:473-83.
32. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
33. Steen VD, Medsger TA, Jr. The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
34. Pilowsky I, Spence N. Manual for the illness behaviour questionnaire (IBQ). 2nd ed. Adelaide, Australia: University of Adelaide; 1983.
35. Evers AW, Kraaimaat FW, van Lankveld W, Jongen PJ, Jacobs JW, Bijlsma JW. Beyond unfavorable thinking: The illness cognition questionnaire for chronic diseases. J Consult Clin Psychol 2001;69:1026-36.
36. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. the st. george's respiratory questionnaire. Am Rev Respir Dis 1992;145:1321-7.
37. Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: A new instrument. J Psychosom Res 1993;37:753-62.
38. Boonen A, van Berkel M, Cieza A, Stucki G, van der Heijde D. Which aspects of functioning are relevant for patients with ankylosing spondylitis: Results of focus group interviews. J Rheumatol 2009;36:2501-11.
39. Stamm TA, Bauernfeind B, Coenen M, Feierl E, Mathis M, Stucki G, et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum 2007;57:1287-95.
40. Newton EG, Thombs BD, Groleau D. The experience of emotional distress among women with scleroderma. Qual Health Res 2012;22:1195-206.
41. Cinar FI, Unver V, Yilmaz S, Cinar M, Yilmaz F, Simsek I et al. Living with scleroderma: Patients' perspectives, a phenomenological study. Rheumatol Int 2012;32:3573-9.
42. Kwakkenbos L, van Lankveld WG, Vonk MC, Becker ES, van den Hoogen FH, van den Ende CH. Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem. J Psychosom Res 2012;72:199-204.
43. Ennis H, Herrick AL, Cassidy C, Griffiths CE, Richards HL. A pilot study of body image dissatisfaction and the psychological impact of systemic sclerosis-related telangiectases. Clin Exp Rheumatol 2013;31:12-7.
44. Steptoe A, Dockray S, Wardle J. Positive affect and psychobiological processes relevant to health. J Pers 2009;77:1747-76.
45. Gard G, Lundvik Gyllensten A. The importance of emotions in physiotherapeutic practice. Phys Ther Rev 2000;5:155-60.
46. Matsuura E, Ohta A, Suematsu R, Inoue H, Koarada S, Tada Y et al. Functional disturbance of the stress-adaptation system in patients with scleroderma. Mod Rheumatol 2011;21:397-405.
47. van Lankveld W, Teunissen H, Näring G, Vonk M, van dH. Social support, disease-related cognitions and coping as predictors of depressed mood in systemic sclerosis. Cognitive Therapy and Research 2008;32:434-47.
48. Ivanoff SD, Hultberg J. Understanding the multiple realities of everyday life: Basic assumptions in focus-group methodology. Scand J Occup Ther 2006;13:125-32.
49. Stamm TA, Nell V, Mathis M, Coenen M, Aletaha D, Cieza A et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum 2007;57:487-94.
50. Pope J. Measures of systemic sclerosis (scleroderma): Health assessment questionnaire (HAQ) and scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, symptom burden index (SBI), university of california, los angeles, scleroderma clinical trials consortium gastrointestinal scale (UCLA SCTC GIT) 2.0, baseline dyspnea index (BDI) and transition dyspnea index (TDI) (mahler's index), Cambridge pulmonary hypertension outcome review (CAMPHOR), and raynaud's condition score (RCS). Arthritis Care Res (Hoboken) 2011;63 (Suppl 11):98-111.